Tectonic Therapeutic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TECX and other ETFs, options, and stocks.About TECX
Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines.
CEOAlise S. Reicin
CEOAlise S. Reicin
Employees51
Employees51
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2015
Founded2015
Employees51
Employees51
TECX Key Statistics
Market cap367.78M
Market cap367.78M
Price-Earnings ratio-5.10
Price-Earnings ratio-5.10
Dividend yield—
Dividend yield—
Average volume404.75K
Average volume404.75K
High today$20.71
High today$20.71
Low today$19.01
Low today$19.01
Open price$19.01
Open price$19.01
Volume382.88K
Volume382.88K
52 Week high$61.07
52 Week high$61.07
52 Week low$13.70
52 Week low$13.70
Stock Snapshot
Tectonic Therapeutic(TECX) stock is priced at $19.66, giving the company a market capitalization of 367.78M. It carries a P/E multiple of -5.10.
On 2025-11-25, Tectonic Therapeutic(TECX) stock moved within a range of $19.01 to $20.71. With shares now at $19.66, the stock is trading +3.4% above its intraday low and -5.1% below the session's peak.
Trading activity shows a volume of 382.88K, compared to an average daily volume of 404.75K.
The stock's 52-week range extends from a low of $13.70 to a high of $61.07.
The stock's 52-week range extends from a low of $13.70 to a high of $61.07.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TECX. This list is generated using Robinhood data, and it’s not a recommendation.